EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis

Ferenc E Mózes iD, Jenny A Lee iD, Yasaman Vali iD, Emmanuel A Selvaraj, Arjun N A Jayaswal iD, Jérôme Boursier, Victor de Lédinghen iD, Monica Lupșor-Platon iD, Yusuf Yilmaz iD, Wah-Kheong Chan iD, Sanjiv Mahadeva, Thomas Karlas iD und 32 weitere

Liver International · 2024-08 · 44 (8) · 1872-1885

DOI: 10.1111/liv.15914 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Liver International, online erschienen am 04.04.2024. Verfasst von Ferenc E Mózes und 43 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, OCMR, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative 2, European Union's Horizon 2020, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims There is a need to reduce the screen failure rate (SFR) in metabolic dysfunction‐associated steatohepatitis (MASH) clinical trials (MASH+F2‐3; MASH+F4) and identify people with high‐risk MASH (MASH+F2‐4) in clinical practice. We aimed to evaluate non‐invasive tests (NITs) screening approaches for these target conditions.

Methods

This was an individual participant data meta‐analysis for the performance of NITs against liver biopsy for MASH+F2‐4, MASH+F2‐3 and MASH+F4. Index tests were the FibroScan‐AST (FAST) score, liver stiffness measured using vibration‐controlled transient elastography (LSM‐VCTE), the fibrosis‐4 score (FIB‐4) and the NAFLD fibrosis score (NFS). Area under the receiver operating characteristics curve (AUROC) and thresholds including those that achieved 34% SFR were reported.

Results

We included 2281 unique cases. The prevalence of MASH+F2‐4, MASH+F2‐3 and MASH+F4 was 31%, 24% and 7%, respectively. Area under the receiver operating characteristics curves for MASH+F2‐4 were .78, .75, .68 and .57 for FAST, LSM‐VCTE, FIB‐4 and NFS. Area under the receiver operating characteristics curves for MASH+F2‐3 were .73, .67, .60, .58 for FAST, LSM‐VCTE, FIB‐4 and NFS. Area under the receiver operating characteristics curves for MASH+F4 were .79, .84, .81, .76 for FAST, LSM‐VCTE, FIB‐4 and NFS. The sequential combination of FIB‐4 and LSM‐VCTE for the detection of MASH+F2‐3 with threshold of .7 and 3.48, and 5.9 and 20 kPa achieved SFR of 67% and sensitivity of 60%, detecting 15 true positive cases from a theoretical group of 100 participants at the prevalence of 24%.

Conclusions

Sequential combinations of NITs do not compromise diagnostic performance and may reduce resource utilisation through the need of fewer LSM‐VCTE examinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesNon-alcoholic Fatty Liver DiseaseHumansROC CurveLiverLiver CirrhosisBiopsyMass Screening

Stichwörter der Autor:innen

FASTFIB‐4LSM‐VCTEMASHNFSat‐risk MASHnon‐invasive tests

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, OCMR, University of Oxford, Oxford, UK.
  • Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
  • Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and the University of Oxford, Oxford, UK.
  • Laboratoire HIFIH, UPRES EA 3859, SFR ICAT 4208, Université d'Angers, Angers, France.
  • Service d'Hépato-Gastroentérologie et Oncologie Digestive, Centre Hospitalier Universitaire d'Angers, Angers, France.

ORCID-Profile: Ferenc E Mózes, Jenny A Lee, Yasaman Vali, Arjun N A Jayaswal, Victor de Lédinghen, Monica Lupșor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Thomas Karlas, Johannes Wiegand, Emmanouil Tsochatzis, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan G Holleboom, Anne-Marieke van Dijk, Hannes Hagström, Won Kim, Takeshi Okanoue, Atsushi Nakajima, Paul J Thuluvath, Annalisa Berzigotti, Stephen A Harrison, Michael Pavlides

Förderung

  • Innovative Medicines Initiative 2
  • European Union's Horizon 2020
  • Wellcome Trust
  • Royal Society

Zitieren

APA

Mózes, F. E., Lee, J. A., Vali, Y., Selvaraj, E. A., Jayaswal, A. N. A., Boursier, J., de Lédinghen, V., Lupșor-Platon, M., Yilmaz, Y., Chan, W. K., Mahadeva, S., Karlas, T., Wiegand, J., Shalimar, Tsochatzis, E., Liguori, A., Wong, V. W., Lee, D. H., Holleboom, A. G., …, & Pavlides, M. (2024). Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis. Liver International, 44(8), 1872-1885. https://doi.org/10.1111/liv.15914

Vancouver

Mózes FE, Lee JA, Vali Y, Selvaraj EA, Jayaswal ANA, Boursier J, et al. Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis. Liver International. 2024;44(8):1872-1885. doi:10.1111/liv.15914

BibTeX
@article{Mzes2024,
  author = {Mózes, Ferenc E and Lee, Jenny A and Vali, Yasaman and Selvaraj, Emmanuel A and Jayaswal, Arjun N A and Boursier, Jérôme and de Lédinghen, Victor and Lupșor-Platon, Monica and Yilmaz, Yusuf and Chan, Wah-Kheong and Mahadeva, Sanjiv and Karlas, Thomas and Wiegand, Johannes and Shalimar and Tsochatzis, Emmanouil and Liguori, Antonio and Wong, Vincent Wai-Sun and Lee, Dae Ho and Holleboom, Adriaan G and van Dijk, Anne-Marieke and Mak, Anne Linde and Hagström, Hannes and Akbari, Camilla and Hirooka, Masashi and Lee, Dong Hyeon and Kim, Won and Okanoue, Takeshi and Shima, Toshihide and Nakajima, Atsushi and Yoneda, Masato and Thuluvath, Paul J and Li, Feng and Berzigotti, Annalisa and Mendoza, Yuly P and Noureddin, Mazen and Truong, Emily and Fournier-Poizat, Céline and Geier, Andreas and Tuthill, Theresa and Yunis, Carla and Anstee, Quentin M and Harrison, Stephen A and Bossuyt, Patrick M and Pavlides, Michael},
  title = {Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH —An individual participant data meta‐analysis},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {8},
  pages = {1872--1885},
  doi = {10.1111/liv.15914}
}
Kostenlos starten →